Loosen, S.H.; van den Bosch, V.; Gorgulho, J.; Schulze-Hagen, M.; Kandler, J.; Jördens, M.S.; Tacke, F.; Loberg, C.; Antoch, G.; Brümmendorf, T.;
et al. Progressive Sarcopenia Correlates with Poor Response and Outcome to Immune Checkpoint Inhibitor Therapy. J. Clin. Med. 2021, 10, 1361.
https://doi.org/10.3390/jcm10071361
AMA Style
Loosen SH, van den Bosch V, Gorgulho J, Schulze-Hagen M, Kandler J, Jördens MS, Tacke F, Loberg C, Antoch G, Brümmendorf T,
et al. Progressive Sarcopenia Correlates with Poor Response and Outcome to Immune Checkpoint Inhibitor Therapy. Journal of Clinical Medicine. 2021; 10(7):1361.
https://doi.org/10.3390/jcm10071361
Chicago/Turabian Style
Loosen, Sven H., Vincent van den Bosch, Joao Gorgulho, Maximilian Schulze-Hagen, Jennis Kandler, Markus S. Jördens, Frank Tacke, Christina Loberg, Gerald Antoch, Tim Brümmendorf,
and et al. 2021. "Progressive Sarcopenia Correlates with Poor Response and Outcome to Immune Checkpoint Inhibitor Therapy" Journal of Clinical Medicine 10, no. 7: 1361.
https://doi.org/10.3390/jcm10071361
APA Style
Loosen, S. H., van den Bosch, V., Gorgulho, J., Schulze-Hagen, M., Kandler, J., Jördens, M. S., Tacke, F., Loberg, C., Antoch, G., Brümmendorf, T., Neumann, U. P., Kuhl, C., Luedde, T., & Roderburg, C.
(2021). Progressive Sarcopenia Correlates with Poor Response and Outcome to Immune Checkpoint Inhibitor Therapy. Journal of Clinical Medicine, 10(7), 1361.
https://doi.org/10.3390/jcm10071361